Detalles de la búsqueda
1.
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
N Engl J Med
; 390(17): 1560-1571, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587254
2.
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.
N Engl J Med
; 384(1): 31-41, 2021 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33200890
3.
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy.
Eur Heart J
; 42(39): 4013-4024, 2021 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34279602
4.
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.
Eur Heart J
; 42(31): 2995-3007, 2021 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33963372
5.
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.
Eur Heart J
; 42(31): 3011-3020, 2021 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34080008
6.
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial.
Circulation
; 141(23): 1841-1854, 2020 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32223318
7.
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI).
Circulation
; 141(14): 1141-1151, 2020 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32178526
8.
Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial.
Stroke
; 52(8): 2494-2501, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33985364
9.
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
Lancet
; 396(10266): 1895-1904, 2020 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33197395
10.
Relation between Baseline Coronary Atherosclerotic Status, Cardiovascular Events, and Malignancies in Type 2 Diabetics: A Long-Term Prospective Cohort Study.
Cardiology
; 146(4): 419-425, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33774635
11.
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Circulation
; 140(23): 1921-1932, 2019 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31557056
12.
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
N Engl J Med
; 377(14): 1319-1330, 2017 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28844192
13.
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.
Gastroenterology
; 157(2): 403-412.e5, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31054846
14.
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.
Gastroenterology
; 157(3): 682-691.e2, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31152740
15.
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
Circulation
; 137(4): 338-350, 2018 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29133605
16.
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER.
Circulation
; 138(8): 756-766, 2018 08 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29626068
17.
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
Lancet
; 391(10117): 219-229, 2018 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29132880
18.
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
N Engl J Med
; 374(21): 2009-20, 2016 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27041480
19.
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
N Engl J Med
; 374(21): 2032-43, 2016 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27039945
20.
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
N Engl J Med
; 374(21): 2021-31, 2016 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27040132